Zacks' 7 Best Stocks for June, 2013
FREE Report for Zacks.com
Visitors Only

They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.

Today, you can see them free.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/22/2013

Company Name Symbol %Change
ALLIANCE FIB AFOP
9.31%
SONIC FOUNDR SOFO
7.77%
VELTI PLC OR VELT
7.58%
TRI TECH HOL TRIT
6.62%
A M R CP AAMRQ
4.52%

Synovus Offloads Distressed Assets

by Zacks Equity Research

December 14, 2012 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Synovus Financial Corp. ( SNV - Analyst Report ) completed the bulk sale of its distressed assets. The selling process was initiated on Dec 10 with an aim to reduce balance sheet risk.

Inclusive of the aforementioned sale, the company anticipates vending distressed assets worth roughly $530 million in the fourth quarter of 2012. This will involve roughly $400 million of non-performing assets, $110 million in accruing substandard rated loans, along with $20 million of loans rated special mention.
The company anticipates incurring a pre-tax charge of $155 million in the fourth quarter as a result of these sales. The Georgia-based lender also anticipates that its deferred tax asset valuation allowance of $787 million will be reversed anytime between the end of the fourth quarter of 2012 and the second quarter of 2013.
Subsequent to the reversal, Synovus will be allowed to make the repayment of bailout funds it received under the Troubled Asset Relief Program (TARP). The company was burdened with approximately $1 billion of bailout since it was having difficulties with bad loans, which plagued it during the housing crisis. The company anticipates repaying of the TARP funds anytime as early as the second quarter of 2013 and not after the fourth quarter of 2013.
Many banks sell their distressed and troubled real estate mortgages in order to get rid of these loss-making investments. Investors try to purchase these loans at a discount and often foreclose principal properties for sale or redevelopment.
Management at Synovus believes that the sale of distressed assets is a pivotal and tactical step in its efforts to further reinforce the balance sheet, enhance credit quality, and improve earnings in the future.
We believe that the restructuring initiatives taken by Synovus will be a key growth driver over time. Moreover, lower non-performing assets and improving operating efficiencies should make the company more profitable in the upcoming quarters. Nevertheless, the sluggish macroeconomic environment and stringent regulations make us cautious.
Synovus currently retains a Zacks #3 Rank, which translates to a short-term Hold rating. However, one of its peers, Cardinal Financial Corp. ( CFNL - Snapshot Report ) , retains a Zacks #1 Rank (a short-term Strong Buy rating).

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.